<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-157384" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Neonatal Seizures and Neonatal Epilepsy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gunasekaran</surname>
            <given-names>Vignesh</given-names>
          </name>
          <aff>West Virginia University Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Govil-Dalela</surname>
            <given-names>Tuhina</given-names>
          </name>
          <aff>Children&#x02019;s Health, Dallas</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vignesh Gunasekaran declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tuhina Govil-Dalela declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>11</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-157384.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Seizures are common in neonates, particularly in the first month of life. Neonatal seizures can be either provoked or unprovoked. Provoked seizures, also known as acute symptomatic seizures, may result from hypoxic-ischemic injury, cerebral infarction, brain bleeds, metabolic derangements, or infections. Unprovoked seizures are often due to underlying structural brain abnormalities or genetic conditions.</p>
        <p>Neonatal epilepsy syndromes are a group of electroclinical syndromes that are considered a medical urgency as they may indicate underlying structural or neuro-metabolic derangements. Although some of these disorders improve over time, others can lead to severe neurodevelopmental consequences, resulting in significant morbidity and mortality.<xref ref-type="bibr" rid="article-157384.r1">[1]</xref><xref ref-type="bibr" rid="article-157384.r2">[2]</xref>&#x000a0;Most&#x000a0;neonatal seizures that occur in the first month of life are acute symptomatic. Neonatal epilepsy syndromes account for a smaller portion of neonatal seizures.<xref ref-type="bibr" rid="article-157384.r3">[3]</xref>&#x000a0;Timely and accurate diagnosis is crucial for initiating appropriate therapy.<xref ref-type="bibr" rid="article-157384.r4">[4]</xref></p>
      </sec>
      <sec id="article-157384.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Underlying causes of neonatal epilepsy syndromes&#x000a0;include genetic mutations, structural brain malformations, and inborn errors of metabolism.</p>
        <p>
<bold>Genetic Abnormalities</bold>
</p>
        <p>Genetic abnormalities are common causes of neonatal epilepsy. Several types of genetic mutations associated with neonatal epilepsy are discussed below.&#x000a0;</p>
        <p><bold>Self-limited neonatal epilepsy:</bold>&#x000a0;The onset of seizures typically occurs on the second or third day of life. Seizures may be tonic, clonic, or autonomic (including apnea and changes in skin color), and typically last up to 30 seconds.&#x000a0;Interictal electroencephalography (EEG) recordings are usually normal but may occasionally show epileptiform discharges. Amplitude-integrated EEG often reveals a distinctive pattern during seizures, characterized by a sudden rise in the upper and lower margins followed by amplitude suppression.<xref ref-type="bibr" rid="article-157384.r5">[5]</xref></p>
        <p>The neurological examination is usually unremarkable. Seizures typically resolve between 6 weeks (65%) and 6 months (94%).<xref ref-type="bibr" rid="article-157384.r6">[6]</xref>&#x000a0;In some cases, a family history of neonatal seizures is present, with an autosomal dominant inheritance pattern. Genetic mutations associated with self-limited neonatal epilepsy include <italic toggle="yes">KCNQ2</italic>, <italic toggle="yes">KCNQ3</italic>, and <italic toggle="yes">SCN2A</italic>. Most children with <italic toggle="yes">KCNQ2-</italic>&#x000a0;or <italic toggle="yes">KCNQ3</italic>-related epilepsy respond well to carbamazepine and other sodium channel blockers.<xref ref-type="bibr" rid="article-157384.r5">[5]</xref></p>
        <p><bold>Early infantile epileptic encephalopathy (Ohtahara syndrome):</bold> Seizure&#x000a0;onset may occur in utero or within the first few days postnatally. This syndrome is often secondary to an underlying structural abnormality. Tonic seizures are commonly observed, along with focal motor and hemiconvulsive seizure types. EEG shows a burst-suppression pattern during both sleep and wakefulness. Seizures are often refractory to treatment, and the syndrome is associated with a poor prognosis. Treatment options, including steroids, valproate, zonisamide, or vitamin B, have been attempted but with limited success.<xref ref-type="bibr" rid="article-157384.r7">[7]</xref>&#x000a0;</p>
        <p><bold>Early myoclonic epileptic encephalopathy:</bold> This syndrome can present within the first few hours to any time during the first month of life and is often attributed to underlying genetic or metabolic causes, with nonketotic hyperglycinemia being the most common. Myoclonic seizures (even generalized myoclonus) are the most common seizure type, although occasional focal seizures may occur. EEG typically shows a burst-suppression pattern, more pronounced during sleep.<xref ref-type="bibr" rid="article-157384.r8">[8]</xref>&#x000a0;This syndrome is associated with a high seizure burden, medically refractory epilepsy, and severe neurodevelopmental morbidity. While myoclonic seizures may resolve within 3 to 4 months, they may progress to tonic seizures. A trial of vitamins may be considered.</p>
        <p><bold><italic toggle="yes">KCNQ2</italic> encephalopathy:</bold> Seizure&#x000a0;onset typically occurs within the first week of life. Neonates present with tonic seizures and exhibit encephalopathy, characterized by hypotonia and visual inattention. EEG reveals abundant multifocal negative sharp waves, which may occasionally meet the criteria for a burst-suppression pattern. Although seizures often resolve by age 3, they are associated with severe global neurodevelopmental delays, regardless of seizure control. Sodium channel blockers are usually effective in treatment.<xref ref-type="bibr" rid="article-157384.r9">[9]</xref></p>
        <p><bold>Developmental delay, epilepsy, and neonatal diabetes syndrome:</bold>&#x000a0;This condition, also known as DEND syndrome, typically presents within the first year of life, often in the neonatal period, where infants with neonatal diabetes experience severe epilepsy. Managing hyperglycemia, usually with oral sulfonylureas, can help control seizures; however, neurodevelopmental delays are commonly observed.&#x000a0;</p>
        <p><bold>Epilepsy of infancy with migrating focal seizures:</bold>&#x000a0;This&#x000a0;condition can present between the third day of life and late infancy in neonates. The primary seizure type is focal, although tonic seizures, epileptic spasms, and autonomic seizures may also occur. EEG may reveal epileptiform discharges, seizure activity with interhemispheric migration, hypsarrhythmia, or burst-suppression patterns. The prognosis is poor, with high mortality rates within the first few years of life and severe neurodevelopmental delays in survivors.</p>
        <p>Genetic mutations in <italic toggle="yes">KCNT1</italic> and <italic toggle="yes">SCN2A</italic> are associated with this epilepsy syndrome. Treatment options include levetiracetam, benzodiazepines, stiripentol, and phenytoin. Children with <italic toggle="yes">SCN2A</italic> mutations presenting before 3 months of age often respond well to sodium channel blockers such as oxcarbazepine and lacosamide,<xref ref-type="bibr" rid="article-157384.r10">[10]</xref>&#x000a0;whereas those with <italic toggle="yes">KCNT1</italic> mutations respond to quinidine.<xref ref-type="bibr" rid="article-157384.r11">[11]</xref></p>
        <p><bold>Pyridoxine-dependent epilepsy:</bold> Pyridoxine-dependent epilepsy is a rare autosomal recessive epilepsy and epileptic encephalopathy caused by antiquitin deficiency due to an underlying <italic toggle="yes">ALDH7A1</italic> mutation. This can be considered a type of early myoclonic epileptic encephalopathy. Seizures typically present in the neonatal period and are refractory to seizure medications. The clinical presentation may also include perinatal asphyxia.</p>
        <p>Imaging abnormalities associated with pyridoxine-dependent epilepsy may include corpus callosum hypoplasia, intracranial hemorrhages, cerebellar hypoplasia, and white matter abnormalities. Seizures typically respond to pyridoxine, pyridoxal-5-phosphate, or folinic acid.<xref ref-type="bibr" rid="article-157384.r12">[12]</xref>&#x000a0;EEG often reveals diffuse high-amplitude rhythmic delta waves with spikes and associated myoclonic seizures.<xref ref-type="bibr" rid="article-157384.r13">[13]</xref></p>
        <p>
<bold>Structural Brain Malformations</bold>
</p>
        <p>Structural brain malformations are a common cause of neonatal epilepsy. These anomalies may include schizencephaly, porencephaly, hemimegalencephaly, subcortical band heterotopia, lissencephaly, and polymicrogyria.</p>
        <p>
<bold>Inborn Errors of Metabolism</bold>
</p>
        <p>Several inborn errors of metabolism with genetic etiologies can cause neonatal seizures. Examples include nonketotic hyperglycinemia, congenital disorders of glycosylation, Zellweger syndrome, isolated sulfite oxidase deficiency, and organic acidurias.</p>
        <p>In certain cases, severe&#x000a0;brain injury during the neonatal period can sometimes lead to acute symptomatic seizures that continue unremittingly and progress into epilepsy.</p>
      </sec>
      <sec id="article-157384.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Neonatal seizures are often challenging to recognize clinically, resulting in poor inter-rater reliability. While EEG remains the gold standard for diagnosis, its ability to capture events during short-term monitoring can be limited. This contributes to challenges in accurately estimating the true incidence of neonatal seizures. However, population studies suggest that neonatal seizures occur in 1 to 3 per 1000 live births for full-term infants.<xref ref-type="bibr" rid="article-157384.r14">[14]</xref></p>
        <p>Neonatal seizures occur in 10 to 30 per 1000 live births for preterm and low-birth-weight infants.<xref ref-type="bibr" rid="article-157384.r15">[15]</xref>&#x000a0;Neonatal epilepsy syndromes are diagnosed in 15% of neonates with seizures. Of these, 41% are attributed to underlying structural anomalies, 42% to genetic causes, and 9% involve an overlap of both factors.<xref ref-type="bibr" rid="article-157384.r16">[16]</xref></p>
      </sec>
      <sec id="article-157384.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Neonates are highly susceptible to seizures due to several factors influencing neuronal excitability. Structurally, the density of the synapses and dendritic spines peaks between birth and the first 1 to 2 months of life. Functionally, overexpression of glutamate receptors, prolonged current decay time of&#x000a0;NMDA (<italic toggle="yes">N</italic>-methyl-D-aspartate)&#x000a0;receptors, and increased excitability of AMPA (&#x003b1;-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors contribute to greater seizure susceptibility. Additionally, inhibitory GABA (gamma-aminobutyric acid) receptor binding and expression are lower during the neonatal period.&#x000a0;Furthermore, the overexpression of the alpha-4 subunit results in decreased sensitivity to benzodiazepines. The reversal of the chloride gradient in the neonatal brain&#x000a0;causes depolarization instead of hyperpolarization with GABA receptor activation, resulting in resistance to GABAa receptor agonists.<xref ref-type="bibr" rid="article-157384.r17">[17]</xref></p>
        <p>Secondary epileptogenesis following acute brain injury involves molecular and cellular mechanisms, including the loss of GABAergic interneurons, increased intracellular chloride, astrogliosis, and alterations in various signaling pathways that promote neuronal excitability.<xref ref-type="bibr" rid="article-157384.r18">[18]</xref></p>
      </sec>
      <sec id="article-157384.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinical history and physical examination are essential in forming a differential diagnosis for abnormal movements in neonates. Gathering information regarding factors that may predispose the baby to seizures is crucial. Physicians should begin by evaluating prenatal risk factors, including a history of infections (such as sexually transmitted infections and TORCH infections), gestational diabetes, pregnancy-related trauma, use of prescription or illicit drugs, and consanguinity.</p>
        <p>In addition, physicians should inquire about the perinatal period, including fetal heart tones during labor, type of delivery, use of delivery instruments, medications administered during delivery, initial APGAR scores, cord blood gas results, the neonatal exam post-delivery, and any postnatal support needed. The circumstances surrounding the seizures should be explored in detail, including the timing of onset, seizure semiology, duration, and response to initial treatment. A family history of seizures or epilepsy may be particularly relevant, especially in cases of self-limited neonatal epilepsy.</p>
        <p>On physical examination, the mental status of neonates is a key feature, as it can aid in identifying epileptic encephalopathies. Dysmorphic features may also be present, suggesting underlying genetic etiologies. Measuring head size is crucial, as congenital or in-utero insults may lead to microcephaly, in addition to underlying genetic etiologies. Macrocephaly may indicate hydrocephalus or certain inborn errors of metabolism. A bulging fontanelle can suggest hydrocephalus, potentially caused by intraventricular hemorrhage, pointing to acute provoked seizures.</p>
        <p>Specific skin findings can often indicate neurocutaneous disorders, such as ash leaf macules associated with tuberous sclerosis, port wine stains in the V1 and V2 distributions linked to Sturge-Weber syndrome, and dermatomal blisters in incontinentia pigmenti.<xref ref-type="bibr" rid="article-157384.r19">[19]</xref>&#x000a0;Tone&#x000a0;is a crucial component of neonatal neurological assessment, as it can help identify the timing of the insult (hypotonia in the acute phase and hypertonicity in the chronic phase) and may also suggest an underlying genetic or structural cause for the seizures.</p>
      </sec>
      <sec id="article-157384.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of seizures in the neonatal age group can be challenging, requiring evaluation alongside treatment. The initial evaluation begins with a detailed history and physical examination, including a thorough neurological assessment. Initial laboratory tests should include blood gas analysis, serum glucose, electrolyte profile, calcium and magnesium levels, liver function tests, ammonia, pyruvate, lactate, serum amino acids, urine organic acids, and acylcarnitine profile.</p>
        <p>Ruling out infection is crucial for any infant presenting with seizures. A full sepsis evaluation should include a complete blood count, blood culture, and cerebrospinal fluid studies, including herpes simplex virus analysis, particularly for infants experiencing seizures in the neonatal period. Identifying an acute provoked cause is also essential, as these are the most common causes of seizures in neonates.</p>
        <p>Seizures in neonates may present with or without clinical signs. Continuous EEG monitoring should be initiated for high-risk neonates. Video EEG is considered the gold standard,<xref ref-type="bibr" rid="article-157384.r20">[20]</xref>&#x000a0;and is recommended&#x000a0;for 24 hours by the American Clinical Neurophysiology Society. A standard 60-minute EEG is considered insufficient as&#x000a0;it takes a median of 7 hours to detect electrographic seizures.<xref ref-type="bibr" rid="article-157384.r21">[21]</xref>&#x000a0;If no seizures are recorded after 24 hours, monitoring may be discontinued, except in patients with hypoxic-ischemic encephalopathy who are undergoing therapeutic hypothermia.</p>
        <p>If seizure activity is detected, EEG should continue until the infant remains seizure-free for 24 to 48 hours. Prolonged EEG monitoring helps characterize the interictal background and classify the seizures.&#x000a0;Amplitude-integrated EEG is considered only when video EEG or continuous EEG is unavailable, as its sensitivity and specificity are lower, and artifacts in these recordings can result in a high false-positive rate.<xref ref-type="bibr" rid="article-157384.r22">[22]</xref>&#x000a0;</p>
        <p>Magnetic resonance imaging (MRI) is the preferred imaging modality for all neonates with seizures. Additional sequencing imaging, such as magnetic resonance angiography or magnetic resonance venography, is performed if arterial ischemic stroke or venous thrombosis is suspected. Magnetic resonance spectroscopy may be useful if an underlying metabolic disorder is suspected. In clinically unstable infants, a head ultrasound can be performed to assess for intraventricular hemorrhage or hydrocephalus. Ultrasounds can be performed at the bedside, making them a&#x000a0;quicker and noninvasive assessment method. The use of computed tomography (CT) scans is restricted in neonates due to concerns about radiation exposure.</p>
        <p>Initial genetic evaluation includes chromosomal microarray, karyotype, and epilepsy genetic panel testing. If no clear cause is identified, whole exome sequencing or whole genome sequencing is recommended for neonates without obvious dysmorphic features. Genetic testing is essential in almost all neonates with epilepsy to guide management and prognosis discussions with the family.<xref ref-type="bibr" rid="article-157384.r16">[16]</xref>&#x000a0;Some of the most commonly identified genetic characteristics associated with specific epileptic diagnoses are listed in the&#x000a0;<bold>Table</bold> below.<xref ref-type="bibr" rid="article-157384.r23">[23]</xref></p>
        <table-wrap id="article-157384.table0" position="float" orientation="portrait">
          <caption>
            <title>Table.&#x000a0;Genetic Characteristics Associated With Neonatal Epilepsy Syndromes</title>
          </caption>
          <table style="width: 800px;" border="1" cellpadding="2">
            <tbody>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p><bold>Epilepsy Syndromes</bold></p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p><bold>Genetic Testing</bold></p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Self-limited neonatal epilepsy</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>An autosomal dominant pattern with incomplete penetrance associated with pathogenic variants <italic toggle="yes">KCNQ2</italic> and <italic toggle="yes">KCNQ3</italic>.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Early infantile epileptic encephalopathy</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Causative pathogenic genes are identified in more than 50% of the cases. Commonly associated variants include <italic toggle="yes">SCN2A</italic>, <italic toggle="yes">SCN8A</italic>, <italic toggle="yes">STXBP1</italic>, <italic toggle="yes">KCNQ2</italic>, <italic toggle="yes">CDKL5</italic>, <italic toggle="yes">UBA5</italic>, and <italic toggle="yes">KCNT1</italic>.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Early myoclonic epileptic encephalopathy</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>A family history of epilepsy or febrile seizures is reported in &#x0003c;10% of cases. No causal gene has been identified.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Epilepsy of infancy with migrating focal seizures</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Rare familial inheritance. De novo gene abnormalities are&#x000a0;implicated, with KCNT1 identified in 50% of patients. Other associated genes include&#x000a0;<italic toggle="yes">SCN1A</italic>, <italic toggle="yes">SCN2A</italic>, <italic toggle="yes">SLC12A5</italic>, and <italic toggle="yes">TBC1D24</italic>.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>DEND syndrome</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>De novo variant or dominant (rarely recessive) inheritance. Activating mutations are observed in the&#x000a0;<italic toggle="yes">KCNJ11</italic> or <italic toggle="yes">ABCC8</italic> genes.</p>
</td>
              </tr>
              <tr style="height: 35px;">
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Pyridoxine-dependent epilepsy</p>
</td>
                <td style="height: 35px;" rowspan="1" colspan="1">
<p>Most cases are associated with biallelic variants in <italic toggle="yes">ALDH7A1;&#x000a0;</italic>a minority&#x000a0;are associated with <italic toggle="yes">PLPBP</italic> mutations.</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-157384.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of seizures in neonates involves identifying the etiology.&#x000a0;Etiology is very important in cases of seizures associated with metabolic derangements such as hypoglycemia and hypocalcemia or in cases of CNS meningitis needing treatment with antivirals/antibiotics/antifungals. The Neonatal Task Force of the International League Against Epilepsy (ILAE)&#x000a0;has developed evidence-based recommendations on antiseizure medications in neonates.<xref ref-type="bibr" rid="article-157384.r24">[24]</xref><xref ref-type="bibr" rid="article-157384.r25">[25]</xref>&#x000a0;The first-line antiseizure medication (ASM) recommended is phenobarbital. Whereas in patients diagnosed with channelopathies, phenytoin or carbamazepine is recommended.&#x000a0;For neonates who do not respond to phenobarbital, second-line antiseizure medications include phenytoin, levetiracetam, midazolam, or lidocaine. A trial dose of pyridoxine can be given to&#x000a0;neonates who present with seizures and are unresponsive to second-line antiseizure medications. Using EEG to guide neonatal seizure treatment helps&#x000a0;clinicians minimize unnecessary exposure to antiseizure medications. The ILAE also recommends discontinuing antiseizure medications after 72 hours of seizure freedom in patients diagnosed with acute provoked seizures, provided there is no evidence of neonatal epilepsy, before discharging them. There is some evidence suggesting that long-term use of phenobarbital may&#x000a0;lead to neuronal apoptosis in immature rats; however, this has not been definitively proven in human neonates.<xref ref-type="bibr" rid="article-157384.r26">[26]</xref>&#x000a0;This is one of the reasons quick discontinuation of&#x000a0;phenobarbital in the acute setting has been suggested.</p>
        <p>Infants at risk for neonatal epilepsy include those with EEG-confirmed seizures lasting more than 3 days, accompanied by a severely abnormal EEG background, or neonates exhibiting abnormal neurological examination findings. These patients should be closely followed up by a pediatric neurologist.<xref ref-type="bibr" rid="article-157384.r27">[27]</xref><xref ref-type="bibr" rid="article-157384.r28">[28]</xref> Neonates with an established diagnosis of neonatal epilepsy should be discharged home on antiseizure medications to help manage and control seizures.</p>
        <p>In the case of neonatal epilepsy, it is essential to classify the types and provide targeted treatment as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Self-limited neonatal epilepsy: Most&#x000a0;cases have spontaneous remission of seizures, but about 30% will have epilepsy later in life. Initial treatment involves a routine ASM pathway. If a clear diagnosis is made, carbamazepine or oxcarbazepine can be effective.<xref ref-type="bibr" rid="article-157384.r29">[29]</xref>&#x000a0;ASM administration can be stopped after 6 weeks.</p>
          </list-item>
          <list-item>
            <p>Early infantile epileptic encephalopathy: Treatment includes a combination of ASM, dietary therapies, and epilepsy surgery in very few infants.<xref ref-type="bibr" rid="article-157384.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Early myoclonic epileptic encephalopathy: Evidence-based treatment is lacking; seizures are treated with standard broad-spectrum ASM.</p>
          </list-item>
          <list-item>
            <p>Epilepsy of infancy with migrating focal seizures: Most seizures are drug-resistant, and outcomes are poor. There have been 4 cases that have achieved complete seizure control. Success has been achieved with the use of different medications such as bromide, clonazepam, stiripentol, and levetiracetam. Vagal nerve stimulation and a ketogenic diet showed inconclusive results.<xref ref-type="bibr" rid="article-157384.r31">[31]</xref><xref ref-type="bibr" rid="article-157384.r32">[32]</xref></p>
          </list-item>
          <list-item>
            <p>DEND syndrome: Oral sulfonylurea has shown tremendous improvement in achieving euglycemia and treating epilepsy.<xref ref-type="bibr" rid="article-157384.r33">[33]</xref></p>
          </list-item>
          <list-item>
            <p>Pyridoxine-dependent epilepsy: ASM is not effective. A trial of IV pyridoxine 100 mg should be performed with EEG and close cardiopulmonary monitoring because of the risk of apneas. This dose can be repeated up to 4 times (maximum dose 500 mg).<xref ref-type="bibr" rid="article-157384.r34">[34]</xref>&#x000a0;In some cases, pyridoxal phosphate is administered as pyridoxine fails to treat seizures in PNPO (pyridoxamine phosphate oxidase) deficiency.<xref ref-type="bibr" rid="article-157384.r35">[35]</xref>&#x000a0;If diagnosed, the recommended dose of pyridoxine for long-term management is 15 to 30 mg/kg/d (up to 200 mg/d in neonates).<xref ref-type="bibr" rid="article-157384.r34">[34]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-157384.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The incidence of seizure activities in the newborn period is higher than at any other stage of life. However, some of the normal newborn behaviors can mimic seizures. Premature neonates have a higher frequency of seizures, and seizures are less organized. In a multicenter study by Murray et al, most seizure-like events were unrecognized and misinterpreted.<xref ref-type="bibr" rid="article-157384.r36">[36]</xref>&#x000a0;Bedside clinical evaluation of the neonate alone may not be sufficient, often requiring confirmatory EEG monitoring.<xref ref-type="bibr" rid="article-157384.r36">[36]</xref>&#x000a0;Inaccurate neonatal seizure diagnosis can lead to adverse consequences. Both undertreatment and overtreatment of seizures can harm the neurological development of the neonate.</p>
        <p>Some of the physiological movements in normal newborn infants that can mimic seizures include neonatal tremors or jitteriness, tremulousness, hyperekplexia, and benign neonatal sleep myoclonus.<xref ref-type="bibr" rid="article-157384.r37">[37]</xref>&#x000a0;Benign neonatal sleep myoclonus can be distinguished from seizures, as myoclonus always stops when the neonate is awake.&#x000a0;</p>
        <p>Hyperekplexia often presents at birth. Newborns can present with generalized stiffness while awake, nocturnal myoclonus, and aggravated startle reflex. These symptoms are more evident when awakening or with stimuli that are atypical for seizures.<xref ref-type="bibr" rid="article-157384.r38">[38]</xref>&#x000a0;Most nonseizure events can be suppressed by restraints or changes in posture, which help distinguish them from seizure events. Scher et al found that 90 percent of abnormal paroxysmal movements suspicious of seizures were found to have normal EEG recordings.<xref ref-type="bibr" rid="article-157384.r39">[39]</xref>&#x000a0;</p>
        <p>Isolated apnea is more common in premature neonates during sleep and is usually associated with desaturations and bradycardia. It is usually nonepileptic in those neonates. An epileptic seizure is suspected when apnea occurs in term neonates and is associated with abnormal eye movements, mouth movements, hypertension, or tachycardia.&#x000a0;</p>
        <p>Sandifer syndrome in neonates is also confused with seizures. Neonates present with paroxysmal head and neck spasms, usually sparing the limbs and back arching.&#x000a0;This syndrome is associated with gastroesophageal reflux. Providing reassurance to the parents is crucial.</p>
        <p>Other symptoms that can mimic seizures include motor automatisms such as repetitive eye opening, eye deviation, tongue movements, or tonic posturing. Patients with these symptoms must be evaluated for underlying nervous system pathology.</p>
      </sec>
      <sec id="article-157384.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of neonatal seizures depends on the underlying pathology. Acute-provoked seizure cases may require a shorter course of treatment; however, patients with epilepsy usually&#x000a0;require continued treatment after discharge.&#x000a0;In the case of self-limited neonatal epilepsy, the prognosis is good with remission of seizures, and very few might present with learning difficulties or mild motor impairment.<xref ref-type="bibr" rid="article-157384.r40">[40]</xref>&#x000a0;However, in individuals with KCNQ2 encephalopathy, seizures resolve within a few months to years in 50%, but affected children present later with moderate to severe global neurodevelopmental disabilities.<xref ref-type="bibr" rid="article-157384.r23">[23]</xref></p>
        <p>The prognosis for early myoclonic epilepsy is poor, with 50% of affected individuals dying within the first few years. Survivors often experience severe developmental delays. Early infantile epileptic encephalopathy,&#x000a0;also known as Ohtahara syndrome,&#x000a0;is associated with&#x000a0;a poor prognosis. Seizures are often refractory and may lead to severe developmental delays, motor disabilities, and a reduced life expectancy.<xref ref-type="bibr" rid="article-157384.r23">[23]</xref><xref ref-type="bibr" rid="article-157384.r41">[41]</xref>&#x000a0;At least half the patients die within the first year of life.</p>
        <p>Pyridoxine-dependent epilepsy has a variable prognosis, ranging from mild to severe intellectual disability, though motor outcomes are generally better. Early diagnosis and appropriate treatment can lead to normal developmental outcomes in some cases. Epilepsy of infancy with migrating focal seizures has a poor prognosis, typically resulting in severe neurological disability and reduced life expectancy in most patients. However, some may experience a milder progression. Genetic testing plays a crucial role in determining the prognosis for many patients with epilepsy.</p>
      </sec>
      <sec id="article-157384.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Neonatal seizures can interfere with normal brain synaptogenesis, resulting in cognitive deficits in some infants. Other serious neurological outcomes include an increased risk of cerebral palsy, especially in infants with extremely low birth weight.<xref ref-type="bibr" rid="article-157384.r42">[42]</xref> Complications associated with neonatal epilepsy vary depending on the specific type diagnosed and can worsen if treatment is delayed. Complications can range from mild learning disabilities to severe neurodevelopmental delays and reduced lifespan. Additionally, some types of epilepsy can result in lifelong, medication-resistant seizures, as detailed in the Prognosis section.</p>
      </sec>
      <sec id="article-157384.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Neonatal epilepsy syndromes, though rare, have a significant impact on a child's neurodevelopment, lifespan, and overall quality of life, affecting not only the child but also the entire family. The team of subspecialists, along with the primary care team, should hold collaborative meetings to discuss the management plan and prognosis. After hospital discharge, close follow-up with&#x000a0;a pediatric neurologist is crucial to monitor and&#x000a0;identify any recurring seizure activity. Families are encouraged to join local networks of parents with children who have seizure disorders for mutual support. These programs vary by community but often include informal gatherings where families can share experiences and foster a supportive environment.&#x000a0;</p>
      </sec>
      <sec id="article-157384.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Neonatal epilepsy syndromes are complex and require care from multiple disciplines. Identifying these syndromes requires a high level of suspicion from the neonatologist, who is often the first to evaluate these infants. When a syndrome is suspected, the neurology, neonatal neurology, and pediatric epilepsy teams are involved for further evaluation. This includes EEG interpretation, determining the underlying cause, managing challenging seizures, predicting neurodevelopmental outcomes, and providing counseling to parents.&#x000a0;</p>
        <p>An interprofessional team is essential for managing complex cases in the hospital and during outpatient follow-up. These neonates often require care from multiple specialists, and a multidisciplinary clinic helps streamline their care while ensuring coordination among specialists. Pediatricians, developmental specialists, pediatric neurologists/epileptologists, physical medicine and rehabilitation specialists, and therapists, all working together to support the child and their family, is optimal.</p>
      </sec>
      <sec id="article-157384.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=157384&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=157384">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/157384/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=157384">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-157384.s14">
        <title>References</title>
        <ref id="article-157384.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilmshurst</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Gaillard</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Vinayan</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Plouin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Van Bogaert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Carrizosa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Craiu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jovic</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Nordli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hirtz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Glauser</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mizrahi</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.</article-title>
            <source>Epilepsia</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>1185</fpage>
            <page-range>1185-97</page-range>
            <pub-id pub-id-type="pmid">26122601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wirrell</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Laux</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Donner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jette</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Knupp</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meskis</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Welborn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel.</article-title>
            <source>Pediatr Neurol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>68</volume>
            <fpage>18</fpage>
            <page-range>18-34.e3</page-range>
            <pub-id pub-id-type="pmid">28284397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anand</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Neonatal seizures: Predictors of adverse outcome.</article-title>
            <source>J Pediatr Neurosci</source>
            <year>2014</year>
            <month>May</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>97</fpage>
            <page-range>97-9</page-range>
            <pub-id pub-id-type="pmid">25250059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clancy</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Summary proceedings from the neurology group on neonatal seizures.</article-title>
            <source>Pediatrics</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>117</volume>
            <issue>3 Pt 2</issue>
            <fpage>S23</fpage>
            <page-range>S23-7</page-range>
            <pub-id pub-id-type="pmid">16777818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vilan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grangeia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ribeiro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Cilio</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Distinctive Amplitude-Integrated EEG Ictal Pattern and Targeted Therapy with Carbamazepine in KCNQ2 and KCNQ3 Neonatal Epilepsy: A Case Series.</article-title>
            <source>Neuropediatrics</source>
            <year>2024</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-41</page-range>
            <pub-id pub-id-type="pmid">37827512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ronen</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Rosales</surname>
                <given-names>TO</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Leppert</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Seizure characteristics in chromosome 20 benign familial neonatal convulsions.</article-title>
            <source>Neurology</source>
            <year>1993</year>
            <month>Jul</month>
            <volume>43</volume>
            <issue>7</issue>
            <fpage>1355</fpage>
            <page-range>1355-60</page-range>
            <pub-id pub-id-type="pmid">8327138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pisani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Spagnoli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Falsaperla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nagarajan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ramantani</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Seizures in the neonate: A review of etiologies and outcomes.</article-title>
            <source>Seizure</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>85</volume>
            <fpage>48</fpage>
            <page-range>48-56</page-range>
            <pub-id pub-id-type="pmid">33418166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beal</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Cherian</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moshe</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Early-onset epileptic encephalopathies: Ohtahara syndrome and early myoclonic encephalopathy.</article-title>
            <source>Pediatr Neurol</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>317</fpage>
            <page-range>317-23</page-range>
            <pub-id pub-id-type="pmid">23044011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r9">
          <label>9</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Miceli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Soldovieri</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Weckhuysen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Taglialatela</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title><italic>KCNQ2</italic>-Related Disorders</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2010</year>
            <month>4</month>
            <day>27</day>
            <pub-id pub-id-type="pmid">20437616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flor-Hirsch</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Heyman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Livneh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reish</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Watemberg</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Litmanovits</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ben Sason Lilli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lev</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lerman Sagie</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bassan</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Lacosamide for SCN2A-related intractable neonatal and infantile seizures.</article-title>
            <source>Epileptic Disord</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>440</fpage>
            <page-range>440-446</page-range>
            <pub-id pub-id-type="pmid">30361185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mullen</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Carney</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Roten</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ching</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lightfoot</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Churilov</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Berkovic</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Petrou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Precision therapy for epilepsy due to <italic>KCNT1</italic> mutations: A randomized trial of oral quinidine.</article-title>
            <source>Neurology</source>
            <year>2018</year>
            <month>Jan</month>
            <day>02</day>
            <volume>90</volume>
            <issue>1</issue>
            <fpage>e67</fpage>
            <page-range>e67-e72</page-range>
            <pub-id pub-id-type="pmid">29196578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Karnebeek</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Tiebout</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Niermeijer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Poll-The</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Ghani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coughlin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Van Hove</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Christen</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Gallagher</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stockler-Ipsiroglu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxine-Dependent Epilepsy: An Expanding Clinical Spectrum.</article-title>
            <source>Pediatr Neurol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>59</volume>
            <fpage>6</fpage>
            <page-range>6-12</page-range>
            <pub-id pub-id-type="pmid">26995068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nabbout</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Soufflet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Plouin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dulac</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxine dependent epilepsy: a suggestive electroclinical pattern.</article-title>
            <source>Arch Dis Child Fetal Neonatal Ed</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>81</volume>
            <issue>2</issue>
            <fpage>F125</fpage>
            <page-range>F125-9</page-range>
            <pub-id pub-id-type="pmid">10448181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasudevan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Levene</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and aetiology of neonatal seizures.</article-title>
            <source>Semin Fetal Neonatal Med</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>185</fpage>
            <page-range>185-91</page-range>
            <pub-id pub-id-type="pmid">23746578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rennie</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Blennow</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Foran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Livingstone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>van Huffelen</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Mathieson</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Pavlidis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weeke</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Toet</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Finder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pinnamaneni</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Marnane</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Boylan</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Characterisation of neonatal seizures and their treatment using continuous EEG monitoring: a multicentre experience.</article-title>
            <source>Arch Dis Child Fetal Neonatal Ed</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>104</volume>
            <issue>5</issue>
            <fpage>F493</fpage>
            <page-range>F493-F501</page-range>
            <pub-id pub-id-type="pmid">30472660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wusthoff</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Glass</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Soul</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wiwattanadittakun</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Abend</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Cilio</surname>
                <given-names>MR</given-names>
              </name>
              <collab>Neonatal Seizure Registry</collab>
            </person-group>
            <article-title>Profile of neonatal epilepsies: Characteristics of a prospective US cohort.</article-title>
            <source>Neurology</source>
            <year>2017</year>
            <month>Aug</month>
            <day>29</day>
            <volume>89</volume>
            <issue>9</issue>
            <fpage>893</fpage>
            <page-range>893-899</page-range>
            <pub-id pub-id-type="pmid">28733343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silverstein</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>FE</given-names>
              </name>
            </person-group>
            <article-title>Neonatal seizures.</article-title>
            <source>Ann Neurol</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>62</volume>
            <issue>2</issue>
            <fpage>112</fpage>
            <page-range>112-20</page-range>
            <pub-id pub-id-type="pmid">17683087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klein</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dingledine</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aronica</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bl&#x000fc;mcke</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Boison</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Brodie</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Brooks-Kayal</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Forcelli</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Kaminski</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Klitgaard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kobow</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lowenstein</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Pearl</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Pitk&#x000e4;nen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Puhakka</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rogawski</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sillanp&#x000e4;&#x000e4;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sloviter</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Steinh&#x000e4;user</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vezzani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>L&#x000f6;scher</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Commonalities in epileptogenic processes from different acute brain insults: Do they translate?</article-title>
            <source>Epilepsia</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-66</page-range>
            <pub-id pub-id-type="pmid">29247482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sivaswamy</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Approach to neonatal seizures.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>2012</year>
            <month>May</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>415</fpage>
            <page-range>415-25</page-range>
            <pub-id pub-id-type="pmid">21937747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Scher</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Riviello</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Abend</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wusthoff</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Clancy</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>The American Clinical Neurophysiology Society's Guideline on Continuous Electroencephalography Monitoring in Neonates.</article-title>
            <source>J Clin Neurophysiol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>611</fpage>
            <page-range>611-7</page-range>
            <pub-id pub-id-type="pmid">22146359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glass</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wusthoff</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Abend</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Cilio</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Glidden</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Bonifacio</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Soul</surname>
                <given-names>JS</given-names>
              </name>
              <collab>Neonatal Seizure Registry Study Group</collab>
            </person-group>
            <article-title>Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study.</article-title>
            <source>J Pediatr</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>174</volume>
            <fpage>98</fpage>
            <page-range>98-103.e1</page-range>
            <pub-id pub-id-type="pmid">27106855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glass</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Wusthoff</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Amplitude-integrated electro-encephalography: the child neurologist's perspective.</article-title>
            <source>J Child Neurol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>28</volume>
            <issue>10</issue>
            <fpage>1342</fpage>
            <page-range>1342-50</page-range>
            <pub-id pub-id-type="pmid">23690296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zuberi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Wirrell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yozawitz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wilmshurst</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Specchio</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Riney</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pressler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Auvin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Samia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Galicchio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Triki</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Snead</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Wiebe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Tinuper</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Perucca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Nabbout</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions.</article-title>
            <source>Epilepsia</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <fpage>1349</fpage>
            <page-range>1349-1397</page-range>
            <pub-id pub-id-type="pmid">35503712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pressler</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Abend</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Auvin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boylan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brigo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cilio</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>De Vries</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Elia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Espeche</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Inder</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jette</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kakooza-Mwesige</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mader</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mizrahi</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Nagarajan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Noyman</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Samia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shany</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Subota</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Triki</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vinayan</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Wilmshurst</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Yozawitz</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Treatment of seizures in the neonate: Guidelines and consensus-based recommendations-Special report from the ILAE Task Force on Neonatal Seizures.</article-title>
            <source>Epilepsia</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>64</volume>
            <issue>10</issue>
            <fpage>2550</fpage>
            <page-range>2550-2570</page-range>
            <pub-id pub-id-type="pmid">37655702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharpe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reiner</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Nespeca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuperman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harbert</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Michelson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Joe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rismanchi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Mower</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Battin</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Honold</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Knodel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Arnell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bridge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ernstrom</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Raman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>RH</given-names>
              </name>
              <collab>NEOLEV2 INVESTIGATORS</collab>
            </person-group>
            <article-title>Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial.</article-title>
            <source>Pediatrics</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>145</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">32385134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittigau</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sifringer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Genz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Reith</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pospischil</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Govindarajalu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dzietko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pesditschek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dikranian</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Olney</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Ikonomidou</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2002</year>
            <month>Nov</month>
            <day>12</day>
            <volume>99</volume>
            <issue>23</issue>
            <fpage>15089</fpage>
            <page-range>15089-94</page-range>
            <pub-id pub-id-type="pmid">12417760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glass</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Grinspan</surname>
                <given-names>ZM</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Abend</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Lemmon</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McCulloch</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
              <collab>Neonatal Seizure Registry Study Group</collab>
            </person-group>
            <article-title>Risk for infantile spasms after acute symptomatic neonatal seizures.</article-title>
            <source>Epilepsia</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>61</volume>
            <issue>12</issue>
            <fpage>2774</fpage>
            <page-range>2774-2784</page-range>
            <pub-id pub-id-type="pmid">33188528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wusthoff</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Numis</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Abend</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Soul</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lemmon</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Guillet</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Franck</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Sturza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCulloch</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Glass</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Early-life epilepsy after acute symptomatic neonatal seizures: A prospective multicenter study.</article-title>
            <source>Epilepsia</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>62</volume>
            <issue>8</issue>
            <fpage>1871</fpage>
            <page-range>1871-1882</page-range>
            <pub-id pub-id-type="pmid">34212365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sands</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Balestri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bellini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mulkey</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Danhaive</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bakken</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Taglialatela</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oldham</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Vigevano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Cilio</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Rapid and safe response to low-dose carbamazepine in neonatal epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>57</volume>
            <issue>12</issue>
            <fpage>2019</fpage>
            <page-range>2019-2030</page-range>
            <pub-id pub-id-type="pmid">27888506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Constantini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ekstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Tripathi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Cossu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rizzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bollo</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Keating</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Oluigbo</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Rutka</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Drake</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jallo</surname>
                <given-names>GI</given-names>
              </name>
              <name>
                <surname>Shimony</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Treiber</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Consales</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mangano</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Wisoff</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Teresa Hidalgo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bingaman</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Erdemir</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sundar</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Benifla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shapira</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Fallah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maniquis</surname>
                <given-names>CAB</given-names>
              </name>
              <name>
                <surname>Tisdall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cinalli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Blount</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Dorfm&#x000fc;ller</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Christine Bulteau</surname>
              </name>
              <name>
                <surname>Uliel-Sibony</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy surgery in infants up to 3 months of age: Safety, feasibility, and outcomes: A multicenter, multinational study.</article-title>
            <source>Epilepsia</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>62</volume>
            <issue>8</issue>
            <fpage>1897</fpage>
            <page-range>1897-1906</page-range>
            <pub-id pub-id-type="pmid">34128544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Merdariu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Delano&#x000eb;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mahfoufi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bellavoine</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Auvin</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam.</article-title>
            <source>Brain Dev</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-80</page-range>
            <pub-id pub-id-type="pmid">22521903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coppola</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Malignant migrating partial seizures in infancy.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2013</year>
            <volume>111</volume>
            <fpage>605</fpage>
            <page-range>605-9</page-range>
            <pub-id pub-id-type="pmid">23622207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea.</article-title>
            <source>J Korean Med Sci</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>1042</fpage>
            <page-range>1042-1045</page-range>
            <pub-id pub-id-type="pmid">28480665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coughlin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Abdenur</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ashmore</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boemer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bok</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buhas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Clayton</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dekker</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Evangeliou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feillet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Footitt</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Gospe</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hartmann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kristensen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lilje</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lunsing</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Papadopoulou</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Pearl</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Piazzon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Plecko</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Saini</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Santra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sjarif</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Stockler-Ipsiroglu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Striano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Van Hove</surname>
                <given-names>JLK</given-names>
              </name>
              <name>
                <surname>Verhoeven-Duif</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Wijburg</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Zuberi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>van Karnebeek</surname>
                <given-names>CDM</given-names>
              </name>
            </person-group>
            <article-title>Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to &#x003b1;-aminoadipic semialdehyde dehydrogenase deficiency.</article-title>
            <source>J Inherit Metab Dis</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>178</fpage>
            <page-range>178-192</page-range>
            <pub-id pub-id-type="pmid">33200442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plecko</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxine and pyridoxalphosphate-dependent epilepsies.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2013</year>
            <volume>113</volume>
            <fpage>1811</fpage>
            <page-range>1811-7</page-range>
            <pub-id pub-id-type="pmid">23622403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murray</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Boylan</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures.</article-title>
            <source>Arch Dis Child Fetal Neonatal Ed</source>
            <year>2008</year>
            <month>May</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>F187</fpage>
            <page-range>F187-91</page-range>
            <pub-id pub-id-type="pmid">17626147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cross</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis of epileptic seizures in infancy including the neonatal period.</article-title>
            <source>Semin Fetal Neonatal Med</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>192</fpage>
            <page-range>192-5</page-range>
            <pub-id pub-id-type="pmid">23642846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakker</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>van Dijk</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>van den Maagdenberg</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Tijssen</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Startle syndromes.</article-title>
            <source>Lancet Neurol</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>513</fpage>
            <page-range>513-24</page-range>
            <pub-id pub-id-type="pmid">16713923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scher</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Painter</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Controversies concerning neonatal seizures.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>1989</year>
            <month>Apr</month>
            <volume>36</volume>
            <issue>2</issue>
            <fpage>281</fpage>
            <page-range>281-310</page-range>
            <pub-id pub-id-type="pmid">2648280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grinton</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Heron</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Pelekanos</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Zuberi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kivity</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Afawi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Casalaz</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Yendle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lev</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lerman-Sagie</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Malone</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bassan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Goldberg-Stern</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hayman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calvert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Korczyn</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Shevell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Mulley</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Berkovic</surname>
                <given-names>SF</given-names>
              </name>
            </person-group>
            <article-title>Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome.</article-title>
            <source>Epilepsia</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>56</volume>
            <issue>7</issue>
            <fpage>1071</fpage>
            <page-range>1071-80</page-range>
            <pub-id pub-id-type="pmid">25982755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radaelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Souza Santos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Borelli</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Pisani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Scorza</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>da Costa</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Causes of mortality in early infantile epileptic encephalopathy: A systematic review.</article-title>
            <source>Epilepsy Behav</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>85</volume>
            <fpage>32</fpage>
            <page-range>32-36</page-range>
            <pub-id pub-id-type="pmid">29906699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157384.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hintz</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Van Meurs</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Pappas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Laptook</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Seizures in extremely low birth weight infants are associated with adverse outcome.</article-title>
            <source>J Pediatr</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>157</volume>
            <issue>5</issue>
            <fpage>720</fpage>
            <page-range>720-5.e1-2</page-range>
            <pub-id pub-id-type="pmid">20542294</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
